eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | erythema multiforme |
| Comorbidity | C0001418|adenocarcinoma |
| Sentences | 1 |
| PubMedID- 24212826 | In a previous study of 156 lung adenocarcinoma patients with measurable target lesions and egfr sequencing results, the patients with egfr mutations (n = 93) had a better response rate (12.9% vs. 1.6%, p = 0.016) and longer pfs (3.9 months vs. 2.3 months, p = 0.030) than those with wild-type egfrs (n = 63) after receiving pemetrexed treatment [28]. |
Page: 1